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     Chlorotoxin is a 36 amino acids peptide, which is able to block chloride channels isolated from mouse 
brain. A derivative of chlorotoxin is synthesized and it is labeled by iodine 131; then animal experiments 
carry out on rats. Multiple organ doses may be calculated with biological distribution results in rats with 
labeled compounds using simulated MCNP4C code. Human dose can be calculated using the dose 
distribution in rats with a conversion ratio for dose distribution. Chloramine T is our method for marking, 
and electrophilic substitution reactions are methods for iodize of peptides. Simulation of a human phantom 
to evaluate dose distribution was done using simulation code MCNP4C. To evaluate the dose distribution 
in the human body, using this code and the accumulated activity in each organ tissue dose is calculated. To 
study the biological distribution of the radiotracer 131I, 0.37 MBq radiotracer was injected into rat via the 
tail vein. The accumulated activity in each organ with the agent “ID / g” is determined. Biological 
distribution of 131I-chlorotoxine in the normal rats is obtained. Its Decay constant in the liver is 0.07h and 
the effective half-life of the radiotracer is 10h in rat liver. The total number of particles found in the leak 
from liver tissue was reported 67600. Liver tissue dosimetries originating from other sources (thyroid 
tissue, stomach, kidney, right & left lung, spleen, and pancreas) were examined. Then, the overall dose to 
the target tissue will be calculated. Leaked beta particles in liver itself (self-dose) are the most delivered 
dose to the liver (98%); it is for gamma rays 1.1%, while its source is adjacent tissues in addition to liver 
(cross-dose); Because of low atomic number of the tissue, delivered dose originated from Bremsstrahlung 
(braking radiation) is low (0.9%). Radiation dose to the liver in intravenous injection of 0.37 MBq  
131
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INTRODUCTION 
      Chlorotoxin is a 36 amino acids peptide, 
which has been extracted the first from the 
venum of scorpion “Leiurus quinquestriatus”. 
Synthetic type of this peptide named TM 601 
commercially [1]. It has been reported that 
extracted toxin from venum of Israeli scorpion is 
able to block chloride channels isolated from 
mouse brain [2]. There was not an appropriate 
marker for definite and certain diagnosis of 
gliomas; it needs to tumor sampling and 
histological evaluations. Chlorotoxin is used in 
diagnosis and treatment of gliomas as a marker 
[3-5, 11, 12]. This peptide is able to pass through 
tissue & blood-brain barriers [3, 6, 10] and attach 
on lamellipodia of cancer cells with phosphatidyl 
inositide of a phosphorylated lipid [7]. Results of 
preclinical and clinical studies have shown that 
attaching of 131I to this peptide could increase 
therapeutic effects of the peptide [3];    they 
synthesized a derivative of chlorotoxin and 
carried out animal experiments on the rats. 
Multiple organ doses may be calculated with 
biological distribution results in rats with labeled 
compounds using simulated MCNP4C code [15, 
16, and 17]. Human dose can be calculated using 
the dose distribution in rats with a conversion 




     Chemicals were purchased from Fluka and 
amino acids from Novabiochem Company. 
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Institute of Nuclear Science and Technology 
provided MCNP4C simulation code. This 
peptide synthesized on the solid phase coloumn, 
based on FMOC standards. Chloramine T is our 
method for marking, and electrophilic 
substitution reactions are methods for iodize of 
peptides. Simulation of a human phantom to 
evaluate dose distribution was performed using 
simulation code MCNP4C.  To evaluate the dose 
distribution in the human body, tissue dose using 
this code and the accumulated activity in each 
organ is calculated. Simulation code MCNP4C 
works on basis of Monte Carlo method and the 
transport of nuclear particles. We calculate the 
dose using F6 tally. To study the biological 
distribution of the radiotracer 131I, 0.37 MBq 
radiotracer was injected into rat via the tail vein. 
The same amount of activity as the control was 
excluded. After intervals of 1, 4 and 24 hours, the 
rat were sacrificed and dissected. The 
accumulated activity in each organ with the agent 
“ID / g” (Injected dose per gram) % is 
determined.
 Equation (1):    
 
 
Organ Count: detector counting from the organ  
Total Count: detector counting from the control 
sample 
W: The organ weight in grams 
B.G: detector counting from background 
radiation 
Basic equation of MIRD (medical internal 
radiation dose): The total radiation dose to the 
target tissue (t) can be calculated using total 
radiation received from the source tissues (s): 
 
Equation (2): D (t) = Ãs .S (t,s) 
 
Equation (3): S (t,s)= Σ(Δi × φi /Mt) 
 
Ãs (μCi-h): accumulation of activity in the 
source tissue 
Mt (g): Mass of the target tissue 
Δi (g.Rad /μCi.h):   Fixed equivalent dose for 
specified type of each particle is here by the 
index i   [8, 13]. φi: a fraction of the energy 
emitted by in  particles of the source tissue that 
are absorbed in target tissue and has been set 
with Monte Carlo calculations [9, 14]. S-factor: 
The absorbed dose per activity unit is 
accumulated in source tissues.  
In order to transfer the experimental animal data 
to Monte Carlo simulation that was designed for 
a human phantom, it is necessary that the animal 
data is converted to human data. In this method, 
data of animal organs as a percentage of the 
injected activity per gram of tissue have been 
reported. It also assumes that percentage of the 
injected activity in the human body is equal to 
the fraction of the total mass of the human body 
to the total mass fraction of animal organs that at 
%ID of animal body is multiplied. The equation 
is as follows: 
 
Equation (4):   
        %ID Human organ = %ID Animal organ  × K 
 


















    After synthesis and labeling processes, labeled 
compound were injected into rat. Rats were 
sacrificed at different times, and their considered 
organs were dissected. Counts were performed 
by counting NaI (Tl). Obtained Data about 
biological distribution is on diagram (1).  
If we assume that a fraction of the injected 
activity A0 is present in the tissue, and 
accompanied by an exponential disposing, two 
processes will be effective in reducing the 
activity: Biological elimination with half-life Tb, 
physical decay constant of radionuclides with 
half-life Tp.  These factors in the effective half-
life as the following are considered. 
 
Equation (6):           Te = Tp ×Tb / (Tp +Tb) 
 




Data were fitted with an exponential function.  
Figure 2 shows the counting results for liver 
tissue. Curve, that is A = A0 e-λt. Thus, the 
effective decay constant in the liver 1 – 0.07h is 
obtained. And using equation (7), effective half-
life of the radiotracer in rat liver is 10h. 
Integrating the surface under the curve count – 
time at the total time period represents the total 
number of Leaked particles in the tissue.  
 
 














This process was performed for all considered 
tissues; the result was a count of 67,600 for 
liver tissue. Using MCNP simulation program, 
mass of human tissues from human phantom is 
obtained; mass of similar animal tissues using 
average tissue of rats was applied in the 
calculations. Accumulate counts in tissues of 
human phantom in figure 3 is given. Simulation 
calculations were performed using MCNP code. 
In this program, the beta energy of 0.61 MeV 
and gamma of 0.38 MeV related to 
131
I  were 
considered as the source of radioactive. Using 
enclosing sphere rejection method, complex 
tissues in terms of geometry, were defined as 
the source. Radius of the sphere on the tissues 
was calculated using Exceed software version 
11.0.0; some results are given in Table (1). F6 
Tally is used at program to obtain the amount of 
leakage energy by beta particles, 
Bremsstrahlung (braking radiation), and 
Gamma photons in target tissue. In order to 
increase the quality factor, the programs were 
run for 30 minutes. Because of low energy 
electrons less the 1keV do not provide any 
direction, energy threshold of 10-3 MeV were 
considered in MCNP  program for exclusion 
these particles.  
 
 






Calculation of decay constant for the liver tissues
 
Radius (cm) Tissue Cell no. 
4 Stomach 1600 
9 Liver 2200 
10 Pancreas 2500 
3 Spleen 2600 
 






Counting of accumulate in human tissues
 
In present study, Liver tissue dosimetries 
originating from other sources (thyroid tissue, 
stomach, kidney, right & left lung, spleen, and 
pancreas) were examined. Entering the command 
FM6 1.602E-7, the energy accumulated in the 
target tissue for a particle accumulated in the 
source was converted to mGy; with effecting 
aggregate counting of the total tissues, Total dose 
to target tissue could be calculated. Table 2 




F6 tally output in liver tissue for beta 




Tissue X -Ray Beta Gamma 
1600 Stomach 6.46E-05 6.46E-05 6.46E-05 
2100 Kidneys 7.75E-05 7.75E-05 7.75E-05 
2200 Liver 6.61E-03 7.04E+00 8.18E-01 
2300 R Lung 1.96E-04 1.53E-04 3.79E-02 
2301 L lung 9.07E-07 1.83E-05 8.23E-03 
2500 Pancreas 4.49E-05 5.34E-05 1.45E-02 
2600 Spleen 1.99E-05 1.68E-05 8.58E-03 
2900 Thyroid 7.55E-06 3.60E-06 2.23E-03 
 
DISCUSSION      
Beta particles of 
131
I have 0.61Mev 
maximum energy and range of them is 
approximately millimeter [10, 11]. 
 If the beta sources located in tissue, the 
particles deposit their energies in tissue 
because the beta particle have millimeter 
rang therefore the source located in liver 
can deposit whole beta energies in it. The 
gamma rays in liver tissue may not fully 
deposit  their  energies in  liver  but  gamma  
rays in surrounding tissue reach to liver and 
can deliver their energies to liver. The 
bremsstrahlung radiation is low because the 
components of liver have low effective 
atomic number. Evaluation of delivered 
dose to the liver tissue for beta particles, 
Bremsstrahlung (braking radiation), and 
gamma rays shows that leaked beta particles 
in liver itself (self-dose) are the most 
delivered dose to the liver (98%); it is for 
gamma rays 1.1%, while its source is 
adjacent tissues in addition to liver (cross-
dose); Because of low atomic number of the 
tissue, delivered dose originated from 
Bremsstrahlung (braking radiation) is low 
(0.9%).  
Radiation dose to the liver in intravenous 
injection of 0.37 MBq  
131
I-chlorotoxine 
radiotracer is 3.44 * 10
-6
. Human phantom 
dosimetry extrapolation also showed that 
excreting organs such as the liver, will not 
receive a significant radiation dose. 
Radiation dose of iodine-131 is more by the 
non-penetrating radiations; contribution of 
penetrating radiation is little; because of 
high-energy photons for the radionuclide 
and the small size of the rat. 
 
CONCLUSION  
    The MCNP simulation code is useful 
program to simulate the absorbed dose in 
the liver and other similar tissues. Basic 
equation of MIRD was done by MCNP 
code for calculation of liver dose. By 
intravenous injection 0.37MBq of 
therapeutic radioisotope in animal, the 
contribution of percent absorbed dose in 
liver for beta, gamma rays and 
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